{"name":"ITEL Telecomunicazioni Srl","slug":"itel-telecomunicazioni-srl","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Radiopharmaceutical 18F-JK-PSMA-7","genericName":"Radiopharmaceutical 18F-JK-PSMA-7","slug":"radiopharmaceutical-18f-jk-psma-7","indication":"PET imaging of PSMA-positive prostate cancer","status":"phase_3"},{"name":"Radiopharmaceutical 18F-Fluorocholine","genericName":"Radiopharmaceutical 18F-Fluorocholine","slug":"radiopharmaceutical-18f-fluorocholine","indication":"Imaging of prostate cancer, breast cancer, and other choline-avid tumors","status":"phase_3"}]}],"pipeline":[{"name":"Radiopharmaceutical 18F-JK-PSMA-7","genericName":"Radiopharmaceutical 18F-JK-PSMA-7","slug":"radiopharmaceutical-18f-jk-psma-7","phase":"phase_3","mechanism":"18F-JK-PSMA-7 is a fluorine-18 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.","indications":["PET imaging of PSMA-positive prostate cancer"],"catalyst":""},{"name":"Radiopharmaceutical 18F-Fluorocholine","genericName":"Radiopharmaceutical 18F-Fluorocholine","slug":"radiopharmaceutical-18f-fluorocholine","phase":"phase_3","mechanism":"18F-Fluorocholine is a radiopharmaceutical that accumulates in cells with high choline uptake, allowing for imaging of cancer cells.","indications":["Imaging of prostate cancer, breast cancer, and other choline-avid tumors"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}